152 related articles for article (PubMed ID: 35533854)
1. Infants' diminished response to DTaP vaccine is associated with exposure to organophosphate esters.
Hammel SC; Nordone S; Zhang S; Lorenzo AM; Eichner B; Moody MA; Harrington L; Gandee J; Schmidt L; Smith S; Stapleton HM; Hoffman K
Sci Total Environ; 2022 Sep; 837():155782. PubMed ID: 35533854
[TBL] [Abstract][Full Text] [Related]
2. Young infants' exposure to organophosphate esters: Breast milk as a potential source of exposure.
Hammel SC; Zhang S; Lorenzo AM; Eichner B; Stapleton HM; Hoffman K
Environ Int; 2020 Oct; 143():106009. PubMed ID: 32771876
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
[TBL] [Abstract][Full Text] [Related]
4. Children's residential exposure to organophosphate ester flame retardants and plasticizers: Investigating exposure pathways in the TESIE study.
Phillips AL; Hammel SC; Hoffman K; Lorenzo AM; Chen A; Webster TF; Stapleton HM
Environ Int; 2018 Jul; 116():176-185. PubMed ID: 29689464
[TBL] [Abstract][Full Text] [Related]
5. Safety of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccine in Adults in Japan.
Ujiie M; Tsuzuki S; Suzuki M; Ota M; Suzuki T; Nomoto H; Yamamoto K; Saito S; Kokaze A; Kinoshita N
Jpn J Infect Dis; 2021 Sep; 74(5):399-404. PubMed ID: 33518629
[TBL] [Abstract][Full Text] [Related]
6. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
[TBL] [Abstract][Full Text] [Related]
7. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
[TBL] [Abstract][Full Text] [Related]
8. Dermal uptake and percutaneous penetration of organophosphate esters in a human skin ex vivo model.
Frederiksen M; Stapleton HM; Vorkamp K; Webster TF; Jensen NM; Sørensen JA; Nielsen F; Knudsen LE; Sørensen LS; Clausen PA; Nielsen JB
Chemosphere; 2018 Apr; 197():185-192. PubMed ID: 29353672
[TBL] [Abstract][Full Text] [Related]
9. Organophosphate ester flame retardants and plasticizers in a Chinese population: Significance of hydroxylated metabolites and implication for human exposure.
Li M; Yao Y; Wang Y; Bastiaensen M; Covaci A; Sun H
Environ Pollut; 2020 Feb; 257():113633. PubMed ID: 31761590
[TBL] [Abstract][Full Text] [Related]
10. Exposure to organophosphate esters and maternal-child health.
Shahin S; Medley EA; Naidu M; Trasande L; Ghassabian A
Environ Res; 2024 Jul; 252(Pt 2):118955. PubMed ID: 38640988
[TBL] [Abstract][Full Text] [Related]
11. Organophosphate Esters: Are These Flame Retardants and Plasticizers Affecting Children's Health?
Doherty BT; Hammel SC; Daniels JL; Stapleton HM; Hoffman K
Curr Environ Health Rep; 2019 Dec; 6(4):201-213. PubMed ID: 31755035
[TBL] [Abstract][Full Text] [Related]
12. Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.
Martinón-Torres F; Halperin SA; Nolan T; Tapiéro B; Perrett KP; de la Cueva IS; García-Sicilia J; Stranak Z; Vanderkooi OG; Kosina P; Rumlarova S; Virta M; Arribas JMM; Miranda-Valdivieso M; Novas BA; Bozensky J; Ortega MJC; Amador JTR; Baca M; Palomino EE; Zuccotti GV; Janota J; Marchisio PG; Kostanyan L; Meyer N; Ceregido MA; Cheuvart B; Kuriyakose SO; Mesaros N
Vaccine; 2021 Mar; 39(11):1598-1608. PubMed ID: 33612341
[TBL] [Abstract][Full Text] [Related]
13. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
Lagos R; Kotloff K; Hoffenbach A; San Martin O; Abrego P; Ureta AM; Pines E; Blondeau C; Bailleux F; Levine MM
Pediatr Infect Dis J; 1998 Apr; 17(4):294-304. PubMed ID: 9576383
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
Schmitt HJ; Zepp F; Müschenborn S; Sümenicht G; Schuind A; Beutel K; Knuf M; Bock HL; Bogaerts H; Clemens R
Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487
[TBL] [Abstract][Full Text] [Related]
15. Comparison of acellular pertussis-tetanus-diphtheria vaccines and whole-cell pertussis-tetanus-diphtheria vaccines in infancy.
Korkmaz HA; Aydin A; Unal B
Paediatr Int Child Health; 2014 Aug; 34(3):198-202. PubMed ID: 24621240
[TBL] [Abstract][Full Text] [Related]
16. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
[TBL] [Abstract][Full Text] [Related]
17. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
[TBL] [Abstract][Full Text] [Related]
18. Absence of a significant interaction between a Haemophilus influenzae conjugate vaccine combined with a diphtheria toxoid, tetanus toxoid and acellular pertussis vaccine in the same syringe and inactivated polio vaccine.
Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Vidor E; Liu X
Pediatr Infect Dis J; 2000 Aug; 19(8):710-7. PubMed ID: 10959738
[TBL] [Abstract][Full Text] [Related]
19. Urinary metabolites of organophosphate esters: Concentrations and age trends in Australian children.
He C; Toms LL; Thai P; Van den Eede N; Wang X; Li Y; Baduel C; Harden FA; Heffernan AL; Hobson P; Covaci A; Mueller JF
Environ Int; 2018 Feb; 111():124-130. PubMed ID: 29195135
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L
Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
